ALVOGEN INC FDA Approval ANDA 062943

ANDA 062943

ALVOGEN INC

FDA Drug Application

Application #062943

Application Sponsors

ANDA 062943ALVOGEN INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 150MG BASE/ML0CLINDAMYCIN PHOSPHATECLINDAMYCIN PHOSPHATE

FDA Submissions

ORIG1AP1988-09-29
LABELING; LabelingSUPPL2AP1991-10-22
LABELING; LabelingSUPPL3AP1991-10-22
LABELING; LabelingSUPPL5AP1994-02-09
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1994-02-23
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1998-08-03
LABELING; LabelingSUPPL8AP2000-10-26
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2001-01-23
LABELING; LabelingSUPPL13AP2004-04-12
LABELING; LabelingSUPPL15AP2005-08-12
LABELING; LabelingSUPPL20AP2008-10-10
LABELING; LabelingSUPPL24AP2013-01-18STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL6Null0
SUPPL7Null0
SUPPL9Null0
SUPPL24Null15

TE Codes

001PrescriptionAP

CDER Filings

ALVOGEN INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62943
            [companyName] => ALVOGEN INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLINDAMYCIN PHOSPHATE","activeIngredients":"CLINDAMYCIN PHOSPHATE","strength":"EQ 150MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CLINDAMYCIN PHOSPHATE","submission":"CLINDAMYCIN PHOSPHATE","actionType":"EQ 150MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.